AP NEWS

Europe Ovarian Cancer Epidemiology and Patient Flow Analysis - 2018 - ResearchAndMarkets.com

July 13, 2018

DUBLIN--(BUSINESS WIRE)--Jul 13, 2018--The “Europe Ovarian Cancer Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.

The research provides insights into Ovarian Cancer epidemiology, Ovarian Cancer diagnosed patients, and Ovarian Cancer treatment rate for EU5 countries. The research measures key indicators including prevalence of Ovarian Cancer derived from epidemiological analysis, patients diagnosed with Ovarian Cancer, and patients treated with a drug therapy.

The research study helps executives estimate Ovarian Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Ovarian Cancer prevalence, Ovarian Cancer diagnosis rate, and Ovarian Cancer treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Topics Covered

1. Ovarian Cancer: Disease Definition

2. Ovarian Cancer Patient Flow in Europe 2A. Ovarian Cancer Prevalence in Europe 2B. Ovarian Cancer Diagnosed Patients in Europe 2C. Ovarian Cancer Treated Patients in Europe

3. Ovarian Cancer Patient Flow in Germany 3A. Ovarian Cancer Prevalence in Germany 3B. Ovarian Cancer Diagnosed Patients in Germany 3C. Ovarian Cancer Treated Patients in Germany

4. Ovarian Cancer Patient Flow in France 4A. Ovarian Cancer Prevalence in France 4B. Ovarian Cancer Diagnosed Patients in France 4C. Ovarian Cancer Treated Patients in France

5. Ovarian Cancer Patient Flow in Spain 5A. Ovarian Cancer Prevalence in Spain 5B. Ovarian Cancer Diagnosed Patients in Spain 5C. Ovarian Cancer Treated Patients in Spain

6. Ovarian Cancer Patient Flow in Italy 6A. Ovarian Cancer Prevalence in Italy 6B. Ovarian Cancer Diagnosed Patients in Italy 6C. Ovarian Cancer Treated Patients in Italy

7. Ovarian Cancer Patient Flow in UK 7A. Ovarian Cancer Prevalence in UK 7B. Ovarian Cancer Diagnosed Patients in UK 7C. Ovarian Cancer Treated Patients in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/279cs4/europe_ovarian?w=4

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005235/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Ovarian Cancer Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/13/2018 09:38 AM/DISC: 07/13/2018 09:38 AM

http://www.businesswire.com/news/home/20180713005235/en

AP RADIO
Update hourly